🇺🇸 FDA

Intelligence Platform

Patents

Browse 302 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6635765

Processes for preparing torsemide intermediate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6630514

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6624292

Processes for preparing clarithromycin polymorphs

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6610718

Processes for making- and a new crystalline form of- leflunomide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6605636

Atorvastatin hemi-calcium form VII

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 12 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6600073

Methods for preparation of sertraline hydrochloride polymorphs

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6599884

Processes for preparing clarithromycin polymorphs and novel polymorph IV

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6592869

Vaccine composition and method of using the same

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576764

Synthesis and crystallization of piperazine ring-containing compounds

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6569459

Method of administration of paclitaxel-plasma protein formulation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6558659

Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids o

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6555585

Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mani

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6545149

Synthesis and crystallization of piperazine ring-containing compounds

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6541001

Vaccine composition and method of using the same

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6538025

Aminoindan derivatives

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6531509

Stable gabapentin containing more than 20 ppm of chlorine ion

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6528661

Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phen

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6528685

Compositions containing and methods of using 1-aminoindan and derivatives thereof and proc

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6500987

Sertraline hydrochloride polymorphs

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6495721

Sertraline hydrochloride Form II and methods for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6492426

Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6482417

Stable pharmaceutical formulation comprising torsemide modification II

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6476006

Composition and dosage form for delayed gastric release of alendronate and/or other bis-ph

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6465496

Torsemide polymorphs

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 15 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired